tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Inhibrx reports Q4 EPS ($3.09) vs. ($6.93) last year

Reports Q4 revenue $100,000 vs. $1.63M last year.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1